Abstract
The interest in the non-nucleoside inhibitors (NNIs) to the reverse transcriptase (RT) as anti-AIDS agents has grown in the last ten years. The compound 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) is the precursor of the most studied class of NNIs, from which hundreds of derivatives have been synthesized and tested. There are at least twelve QSAR studies about the HEPT derivatives as RT inhibitors. Most of the predictions derived by these studies are related to the nature of the active site near the substituents at positions N-1 and C-5, and at the C-6 phenyl ring. The validity of these models has been checked against the 3-D structure of HIV 1 RT-HEPT complexes available. Most of these predictions were confirmed at the molecular level.
Similar content being viewed by others
References
Pedersen, O.S. and Pedersen, E.B., Antivir. Chem. Chemother., 10 (1999) 285.
De Clercq, E., Farmaco, 54 (1999) 26.
De Clercq, E., Antiviral Res., 38 (1998) 153.
Molla, A. and Japour, A., Curr. Opin. Infect. Dis., 10 (1997) 491.
Flexner, C.N., Engl. J. Med., 338 (1998) 1281.
Patick, A.K. and Potts, K.E., Clin. Microbiol. Rev., 11 (1998) 614.
Kakuda, T.N., Struble, K.A. and Piscitelli, S.C., Am. J. Health-Syst. Pharm., 55 (1998) 233.
Rana, K.Z. and Dudley, M.N., Pharmacotherapy, 19 (1999) 35.
Miyasaka, T., Tanaka, H., Baba, M., Hayakawa, H., Walker, R.T., Balzarini, J. and De Clercq, E., J. Med. Chem., 32 (1989) 2507.
Tanaka, H., Baba, M., Hayakawa, H., Sakamaki, T., Miyasaka, T., Ubasawa, M., Takashima, H., Sekiya, K., Nitta, I., Shigeta, S., Walker, R.T., Balzarini, J. and De Clercq, E., J. Med. Chem., 34 (1991) 349.
Tanaka, H., Baba, M., Ubasawa, M., Takashima, H., Sekiya, K., Nitta, I., Shigeta, S., Walker, R.T., De Clercq, E. and Miyasaka, T., J. Med. Chem., 34 (1991) 1394.
Tanaka, H., Takashima, H., Ubasawa,M., Sekiya, K., Inouye, N., Baba, M., Shigeta, S., Walker, R.T., De Clercq, E. and Miyasaka, T., J. Med. Chem., 38 (1995) 2860.
Tanaka, H., Baba, M., Yamamoto, T., Mori, S., Walker, R.T., De Clercq, E. and Miyasaka, T., Bioorg. Med. Chem. Lett., 3 (1993) 1681.
Tanaka, H., Takashima, H., Ubasawa, M., Sekiya, K., Nitta, I., Baba, M., Shigeta, S., Walker, R.T., De Clercq, E. and Miyasaka, T., J. Med. Chem., 35 (1992) 4713.
Tanaka, H., Takashima, H., Ubasawa, M., Sekiya, K., Nitta, I., Baba, M., Shigeta, S., Walker, R.T., De Clercq, E. and Miyasaka, T., J. Med. Chem., 35 (1992) 337.
Hopkins, A.L., Ren, J., Esnouf, R.M., Willcox, B.E., Jones, E.Y., Ross, C., Miyasaka, T., Walker, R.T., Tanaka, H., Stammers, D.K. and Stuart, D.I., J. Med. Chem., 39 (1996) 1589.
Ren, J.S., Esnouf, R., Garman, E., Somers, D., Ross, C., Kirby, I., Keeling, J., Darby, G., Jones, Y., Stuart, D. and Stammers, D., Nature Struct. Biol., 2 (1995) 293.
Hansch, C. and Zhang, L.T., Bioorg. Med. Chem. Lett., 2 (1992) 1165.
Hannongbua, S., Lawtrakul, L., Sotriffer, C.A. and Rode, B.M., Quant. Struct.-Act. Relat., 15 (1996) 389.
Hannongbua, S., Lawtrakul, L. and Limtrakul, J., J. Comput.-Aided Mol. Des., 10 (1996) 145.
Garg, R., Kurup, A. and Gupta, S.P., Quant. Struct.-Act. Relat., 16 (1997) 20.
Kireev, D.B., Chrétien, J.R., Grierson, D.S. and Monneret, C., J. Med. Chem., 40 (1997) 4257.
Luco, J.M. and Ferretti, F.H., J. Chem. Inf. Comp. Sci., 37 (1997) 392.
Tronchet, J.M.J., Grigorov, M., Dolatshahi, N., Moriaud, F. and Weber, J., Eur. J. Med. Chem., 32 (1997) 279.
Garg, R., Gupta, S.P., Gao, H., Babu, M.S., Debnath, A.K. and Hansch, C., Chem. Rev., 99 (1999) 3525.
Lawtrakul, L. and Hannongbua, S., Sci. Pharm., 67 (1999) 43.
Jalali-Heravi, M. and Parastar, F., J. Chem. Inf. Comp. Sci., 40 (2000) 147.
Alves, C.N., Pinheiro, J.C., Camargo, A.J., Ferreira, M.M.C. and Da Silva, A.B.F.,J. Mol. Struct. (Theochem), 530 (2000) 39.
Hannongbua, S., Nivesanond, K., Lawtrakul, L., Pungpo, P. and Wolschann, P., J. Chem. Inf. Comp. Sci., 41 (2001) 848.
De Oliveira, D.B. and Gaudio, A.C., Quant. Struct.-Act. Relat., 19 (2000) 599.
Berman, H.M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T.N., Weissig, H., Shindyalov, I.N. and Bourne, P.E., Nucl. Acids Res., 28 (2000) 235.
BioMedCAChe 5.0, Fujitsu Ltd., Tokio, 2000.
WebLab Viewer Pro 4.0, Molecular Simulations, Inc., San Diego-CA, 2000.
Fujita, T., Hansch, C. and Iwasa, J., J. Am. Chem. Soc., 86 (1964) 5175.
R. Mannhold, P. Krogsgaard-Larsen and H. Timmerman (Eds.), QSAR: Hansch Analysis and Related Approaches, Vol. 1, VCH, Weinheim, 1993.
Taft, R.W., Jr., J. Am. Chem. Soc., 74 (1952) 3120.
Tanaka, H., Baba, M., Takahashi, E., Matsumoto, K., Kittaka, A., Walker, R.T., De Clercq, E. and Miyasaka, T., Nucleosides Nucleotides, 13 (1994) 155.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gaudio, A.C., Montanari, C.A. HEPT derivatives as non-nucleoside inhibitors of HIV-1 reverse transcriptase: QSAR studies agree with the crystal structures. J Comput Aided Mol Des 16, 287–295 (2002). https://doi.org/10.1023/A:1020280627193
Issue Date:
DOI: https://doi.org/10.1023/A:1020280627193